Kim Marturano is a Principal Quality Engineer at Glaukos Corporation, where she leverages her extensive experience in the pharmaceuticals industry to drive quality assurance initiatives and enhance manufacturing processes. With a robust background in biotechnology, Kim specializes in the tech transfer of clinical ophthalmic pharmaceuticals,...
Kim Marturano is a Principal Quality Engineer at Glaukos Corporation, where she leverages her extensive experience in the pharmaceuticals industry to drive quality assurance initiatives and enhance manufacturing processes. With a robust background in biotechnology, Kim specializes in the tech transfer of clinical ophthalmic pharmaceuticals, ensuring that new products are seamlessly integrated into existing manufacturing frameworks. Her expertise in cell culture, purification, and ultrafiltration positions her as a key player in the development and optimization of processes that meet stringent FDA and cGMP regulations.
In her current role, Kim is responsible for the meticulous review of batch records, lot disposition, and lot release for both commercial and clinical pharmaceutical products produced at Contract Manufacturing Organizations (CMOs). She has successfully performed lot release for over 70 commercial batches and several clinical lots, demonstrating her commitment to maintaining the highest quality standards. Her proficiency in writing standard operating procedures (SOPs), protocols, and technical reports ensures that all documentation meets regulatory requirements and supports continuous improvement efforts.
Kim’s collaborative approach fosters effective communication across cross-functional teams, enabling her to drive projects that enhance operational efficiency and product quality. Her deep understanding of technology transfer processes and her ability to navigate complex regulatory landscapes make her an invaluable asset to Glaukos Corporation. As she continues to contribute to the advancement of ophthalmic pharmaceuticals, Kim remains dedicated to fostering innovation and excellence in the field, ensuring that patients receive safe and effective therapies.
